Treatment of Patients With Blepharitis and Facial Rosacea

NCT00560703 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharitis
Meibomianitis
Dry Eye

Interventions

DRUG: COL-101 (doxycycline, USP) capsules
DRUG: placebo

Sponsor

Galderma R&D